IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Danish Biopharma Company Secures $500-Million U.S. Contract

10:07 AM MDT | June 28, 2007 | Alex Scott

The outsourcing of vaccine manufacturing took a step up in scale earlier this month, when the U.S. Department of Health and Human Services (HHS) disclosed that it had agreed to contract out the manufacture of 20 million doses of smallpox vaccine to biopharmaceutical company Bavarian Nordic (Kvistgård, Denmark) for $500 million. The U.S. government will add the purchased supplies of the vaccine, dubbed Imvamune, to its strategic national stockpile for individuals that are considered at risk, including those individuals with low levels of immunity. HHS has...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa